Former soldier Daniel Khalife has denied asking Iranian agents for help after he escaped from prison. The 23-year-old told ...

Truist Financial analyst Richard Newitter maintained a Hold rating on Nevro Corp (NVRO – Research Report) today and set a price target of $7.00. The company’s shares closed yesterday at $5.06.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

Q3 2024 Earnings Call Transcript November 11, 2024 Nevro Corp. beats earnings expectations. Reported EPS is $-0.51, ...

Baird reaffirms Nevro with a Neutral and raises the price target from $5 to $6. RBC Capital reiterates Nevro with a Sector ...

Piper Sandler analyst Adam Maeder assigned a Sell rating to Nevro Corp (NVRO – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $5.32. Maeder covers the ...

Q3 2024 Earnings Conference Call November 11, 2024 4:30 PM ETCompany ParticipantsAngie McCabe - Vice President, Investor ...

Nevro (NVRO) delivered earnings and revenue surprises of 37.80% and 4.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Nevro (NYSE:NVRO) is scheduled to announce Q3 earnings results on Monday, November 11th, after market close. The consensus EPS Estimate is -$0.84 (-29.2% Y/Y) and the consensus Revenue Estimate is ...

Nevro (NYSE:NVRO – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, ...